Zentalis Pharmaceuticals's total assets for Q1 2025 were $384.02M, a decrease of -10.76% from the previous quarter. ZNTL total liabilities were $88.64M for the fiscal quarter, a -4.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.